Stem cell-based therapy for human diseases

被引:598
作者
Hoang, Duc M. [1 ]
Pham, Phuong T. [2 ]
Bach, Trung Q. [1 ]
Ngo, Anh T. L. [2 ]
Nguyen, Quyen T. [1 ]
Phan, Trang T. K. [1 ]
Nguyen, Giang H. [1 ]
Le, Phuong T. T. [1 ]
Hoang, Van T. [1 ]
Forsyth, Nicholas R. [3 ]
Heke, Michael [4 ]
Liem Thanh Nguyen [1 ]
机构
[1] Vinmec Healthcare Syst, Dept Res & Dev, Vinmec Res Inst Stem Cell & Gene Technol, Hanoi, Vietnam
[2] Vinmec Healthcare Syst, Dept Cellular Therapy, Vinmec High Tech Ctr, Hanoi, Vietnam
[3] Keele Univ, Inst Sci & Technol Med, Keele, Staffs, England
[4] Stanford Univ, Dept Biol, Stanford, CA USA
关键词
MESENCHYMAL STROMAL CELLS; SPINAL-CORD-INJURY; ENDOTHELIAL GROWTH-FACTOR; HUMAN BONE-MARROW; CHRONIC LIVER-FAILURE; REFRACTORY CROHNS-DISEASE; COLONY-STIMULATING FACTOR; PLACEBO-CONTROLLED TRIAL; ISCHEMIC-HEART FAILURE; PLATELET-RICH PLASMA;
D O I
10.1038/s41392-022-01134-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent advancements in stem cell technology open a new door for patients suffering from diseases and disorders that have yet to be treated. Stem cell-based therapy, including human pluripotent stem cells (hPSCs) and multipotent mesenchymal stem cells (MSCs), has recently emerged as a key player in regenerative medicine. hPSCs are defined as self-renewable cell types conferring the ability to differentiate into various cellular phenotypes of the human body, including three germ layers. MSCs are multipotent progenitor cells possessing self-renewal ability (limited in vitro) and differentiation potential into mesenchymal lineages, according to the International Society for Cell and Gene Therapy (ISCT). This review provides an update on recent clinical applications using either hPSCs or MSCs derived from bone marrow (BM), adipose tissue (AT), or the umbilical cord (UC) for the treatment of human diseases, including neurological disorders, pulmonary dysfunctions, metabolic/endocrine-related diseases, reproductive disorders, skin burns, and cardiovascular conditions. Moreover, we discuss our own clinical trial experiences on targeted therapies using MSCs in a clinical setting, and we propose and discuss the MSC tissue origin concept and how MSC origin may contribute to the role of MSCs in downstream applications, with the ultimate objective of facilitating translational research in regenerative medicine into clinical applications. The mechanisms discussed here support the proposed hypothesis that BM-MSCs are potentially good candidates for brain and spinal cord injury treatment, AT-MSCs are potentially good candidates for reproductive disorder treatment and skin regeneration, and UC-MSCs are potentially good candidates for pulmonary disease and acute respiratory distress syndrome treatment.
引用
收藏
页数:41
相关论文
共 495 条
[1]   Mechanical and Chemical Predifferentiation of Mesenchymal Stem Cells Into Cardiomyocytes and Their Effectiveness on Acute Myocardial Infarction [J].
Abd Emami, Baharak ;
Mahmoudi, Elena ;
Shokrgozar, Mohammad Ali ;
Dehghan, Mohammad Mehdi ;
Mohajeri, Saeed Farzad ;
Haghighipour, Nooshin ;
Marjanmehr, Seyyed Hossein ;
Molazem, Mohammad ;
Amin, Susan ;
Gholami, Hossein .
ARTIFICIAL ORGANS, 2018, 42 (06) :E114-E126
[2]  
Abo-Elkheir W, 2017, AM J STEM CELLS, V6, P23
[3]   The Systematic Effect of Mesenchymal Stem Cell Therapy in Critical COVID-19 Patients: A Prospective Double Controlled Trial [J].
Adas, G. ;
Cukurova, Z. ;
Yasar, K. Kart ;
Yilmaz, R. ;
Isiksacan, N. ;
Kasapoglu, P. ;
Yesilbag, Z. ;
Koyuncu, I. D. ;
Karaoz, E. .
CELL TRANSPLANTATION, 2021, 30
[4]   Male infertility [J].
Agarwal, Ashok ;
Baskaran, Saradha ;
Parekh, Neel ;
Cho, Chak-Lam ;
Henkel, Ralf ;
Vij, Sarah ;
Arafa, Mohamed ;
Selvam, Manesh Kumar Panner ;
Shah, Rupin .
LANCET, 2021, 397 (10271) :319-333
[5]   Stem cells for bronchopulmonary dysplasia in preterm infants: A randomized controlled phase II trial [J].
Ahn, So Yoon ;
Chang, Yun Sil ;
Lee, Myung Hee ;
Sung, Se In ;
Lee, Byong Sop ;
Kim, Ki Soo ;
Kim, Ai-Rhan ;
Park, Won Soon .
STEM CELLS TRANSLATIONAL MEDICINE, 2021, 10 (08) :1129-1137
[6]   The CCL5/CCR5 Axis in Cancer Progression [J].
Aldinucci, Donatella ;
Borghese, Cinzia ;
Casagrande, Naike .
CANCERS, 2020, 12 (07) :1-30
[7]   Adipose-Derived Mesenchymal Stem Cells Isolated from Patients with Type 2 Diabetes Show Reduced "Stemness" through an Altered Secretome Profile, Impaired Anti-Oxidative Protection, and Mitochondrial Dynamics Deterioration [J].
Alicka, Michalina ;
Major, Piotr ;
Wysocki, Michal ;
Marycz, Krzysztof .
JOURNAL OF CLINICAL MEDICINE, 2019, 8 (06)
[8]  
Alkhalil Moustafa, 2015, Med Glas (Zenica), V12, P27
[9]   Dynamic of distribution of human bone marrow-derived mesenchymal stem cells after transplantation into adult unconditioned mice [J].
Allers, C ;
Sierralta, WD ;
Neubauer, S ;
Rivera, F ;
Minguell, JJ ;
Conget, PA .
TRANSPLANTATION, 2004, 78 (04) :503-508
[10]   Off-label mesenchymal stromal cell treatment in two infants with severe bronchopulmonary dysplasia: clinical course and biomarkers profile [J].
Alvarez-Fuente, Maria ;
Arruza, Luis ;
Lopez-Ortego, Paloma ;
Moreno, Laura ;
Ramirez-Orellana, Manuel ;
Labrandero, Carlos ;
Gonzalez, Africa ;
Melen, Gustavo ;
Jesus del Cerro, Maria .
CYTOTHERAPY, 2018, 20 (11) :1337-1344